276 related articles for article (PubMed ID: 22441386)
1. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.
Alam MM; Riyadh MA; Fatema K; Rahman MA; Akhtar N; Ahmed T; Chowdhury MI; Chowdhury F; Calderwood SB; Harris JB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2011 May; 18(5):844-50. PubMed ID: 21346055
[TBL] [Abstract][Full Text] [Related]
3. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
[TBL] [Abstract][Full Text] [Related]
5. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
Uddin T; Aktar A; Xu P; Johnson RA; Rahman MA; Leung DT; Afrin S; Akter A; Alam MM; Rahman A; Chowdhury F; Khan AI; Bhuiyan TR; Bufano MK; Rashu R; Yu Y; Wu-Freeman Y; Harris JB; LaRocque RC; Charles RC; Kováč P; Calderwood SB; Ryan ET; Qadri F
Am J Trop Med Hyg; 2014 May; 90(5):873-81. PubMed ID: 24686738
[TBL] [Abstract][Full Text] [Related]
6. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh.
Leung DT; Rahman MA; Mohasin M; Riyadh MA; Patel SM; Alam MM; Chowdhury F; Khan AI; Kalivoda EJ; Aktar A; Bhuiyan MS; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2011 Aug; 18(8):1317-25. PubMed ID: 21697337
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
Haney DJ; Lock MD; Gurwith M; Simon JK; Ishioka G; Cohen MB; Kirkpatrick BD; Lyon CE; Chen WH; Sztein MB; Levine MM; Harris JB
Vaccine; 2018 May; 36(20):2768-2773. PubMed ID: 29655627
[TBL] [Abstract][Full Text] [Related]
8. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.
Aktar A; Rahman MA; Afrin S; Faruk MO; Uddin T; Akter A; Sami MIN; Yasmin T; Chowdhury F; Khan AI; Leung DT; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2016 May; 23(5):427-435. PubMed ID: 27009211
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children.
Uddin MI; Islam S; Nishat NS; Hossain M; Rafique TA; Rashu R; Hoq MR; Zhang Y; Saha A; Harris JB; Calderwood SB; Bhuiyan TR; Ryan ET; Leung DT; Qadri F
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005039. PubMed ID: 27824883
[TBL] [Abstract][Full Text] [Related]
10. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera.
Arifuzzaman M; Rashu R; Leung DT; Hosen MI; Bhuiyan TR; Bhuiyan MS; Rahman MA; Khanam F; Saha A; Charles RC; LaRocque RC; Weil AA; Clements JD; Holmes RK; Calderwood SB; Harris JB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2012 Aug; 19(8):1304-11. PubMed ID: 22739692
[TBL] [Abstract][Full Text] [Related]
12. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age.
Saha A; Chowdhury MI; Khanam F; Bhuiyan MS; Chowdhury F; Khan AI; Khan IA; Clemens J; Ali M; Cravioto A; Qadri F
Vaccine; 2011 Oct; 29(46):8285-92. PubMed ID: 21907255
[TBL] [Abstract][Full Text] [Related]
14. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine.
Alam MM; Leung DT; Akhtar M; Nazim M; Akter S; Uddin T; Khanam F; Mahbuba DA; Ahmad SM; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2013 Oct; 20(10):1541-8. PubMed ID: 23925888
[TBL] [Abstract][Full Text] [Related]
15. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
Aktar A; Rahman MA; Afrin S; Akter A; Uddin T; Yasmin T; Sami MIN; Dash P; Jahan SR; Chowdhury F; Khan AI; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006399. PubMed ID: 29684006
[TBL] [Abstract][Full Text] [Related]
16. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
[TBL] [Abstract][Full Text] [Related]
17. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
Islam K; Hossain M; Kelly M; Mayo Smith LM; Charles RC; Bhuiyan TR; Kováč P; Xu P; LaRocque RC; Calderwood SB; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006376. PubMed ID: 29624592
[TBL] [Abstract][Full Text] [Related]
18. Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.
Dash P; Hakim A; Akter A; Banna HA; Kaisar MH; Aktar A; Jahan SR; Ferdous J; Basher SR; Kamruzzaman M; Chowdhury F; Akter A; Tauheed I; Weil AA; Charles RC; Calderwood SB; Ryan ET; LaRocque RC; Harris JB; Bhuiyan TR; Qadri F
mSphere; 2024 Mar; 9(3):e0056523. PubMed ID: 38391226
[TBL] [Abstract][Full Text] [Related]
19. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET
mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti.
Charles RC; Hilaire IJ; Mayo-Smith LM; Teng JE; Jerome JG; Franke MF; Saha A; Yu Y; Kováč P; Calderwood SB; Ryan ET; LaRocque RC; Almazor CP; Qadri F; Ivers LC; Harris JB
PLoS Negl Trop Dis; 2014 May; 8(5):e2828. PubMed ID: 24786645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
